clinical trials

August 10, 2022 · Christopher Flowers, MD, MS, FASCO; Vicki Keedy, MD; Daniel Mulrooney, MD, MS; and Sumanta (Monty) Pal, MD, FASCO
In this post, several experts describe the importance of peer-reviewed cancer information, including what “peer reviewed” means, what to know about levels of scientific evidence in cancer research, and the differences between research done in cell lines, animals, and humans. Read More >>
June 15, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning. Read More >>
2022 ASCO Annual Meeting; #ASCO22
May 26, 2022 · Greg Guthrie, ASCO Staff
La Reunión Anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) de 2022 se llevará a cabo del 3 al 7 de junio. En esta publicación inicial de la investigación que se presenta en la reunión, los estudios examinan cómo la raza, el origen étnico, la pobreza y otros factores sociales y demográficos afectan la vida de las personas con cáncer. Read More >>
2022 ASCO Annual Meeting; #ASCO22
May 26, 2022 · Greg Guthrie, ASCO Staff
The 2022 ASCO Annual Meeting is being held June 3 to 7. In this early release of research being presented at the meeting, studies examine how race, ethnicity, poverty, and other social and demographic factors affect the lives of people with cancer. Read More >>
December 21, 2021 · Jyoti Patel, MD, FASCO
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses the disparities that exist in cancer clinical trials and how cancer care providers are working to address the barriers to participation in clinical trials for minority populations. Read More >>

Pages